Unknown

Dataset Information

0

Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay.


ABSTRACT: Adiponectin, the adipose-derived hormone, plays an important role in the suppression of metabolic disorders that can result in type 2 diabetes, obesity, and atherosclerosis. It has been shown that up-regulation of adiponectin or adiponectin receptor has a number of therapeutic benefits. Given that it is hard to convert the full size adiponectin protein into a viable drug, adiponectin receptor agonists could be designed or identified using high-throughput screening. Here, we report on the development of a two-step screening process to identify adiponectin agonists. First step, we developed a high throughput screening assay based on fluorescence polarization to identify adiponectin ligands. The fluorescence polarization assay reported here could be adapted to screening against larger small molecular compound libraries. A natural product library containing 10,000 compounds was screened and 9 hits were selected for validation. These compounds have been taken for the second-step in vitro tests to confirm their agonistic activity. The most active adiponectin receptor 1 agonists are matairesinol, arctiin, (-)-arctigenin and gramine. The most active adiponectin receptor 2 agonists are parthenolide, taxifoliol, deoxyschizandrin, and syringin. These compounds may be useful drug candidates for hypoadiponectin related diseases.

SUBMITTER: Sun Y 

PROVIDER: S-EPMC3653934 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay.

Sun Yiyi Y   Zang Zhihe Z   Zhong Ling L   Wu Min M   Su Qing Q   Gao Xiurong X   Zan Wang W   Lin Dong D   Zhao Yan Y   Zhang Zhonglin Z  

PloS one 20130514 5


Adiponectin, the adipose-derived hormone, plays an important role in the suppression of metabolic disorders that can result in type 2 diabetes, obesity, and atherosclerosis. It has been shown that up-regulation of adiponectin or adiponectin receptor has a number of therapeutic benefits. Given that it is hard to convert the full size adiponectin protein into a viable drug, adiponectin receptor agonists could be designed or identified using high-throughput screening. Here, we report on the develop  ...[more]

Similar Datasets

| S-EPMC3176662 | biostudies-literature
| S-EPMC9781101 | biostudies-literature
| S-EPMC4677366 | biostudies-literature
| S-EPMC3152590 | biostudies-literature
| S-EPMC2440576 | biostudies-literature
| S-EPMC9590608 | biostudies-literature
| S-EPMC4112551 | biostudies-literature
| S-EPMC5800469 | biostudies-literature
| S-EPMC6594354 | biostudies-literature
| S-EPMC11537999 | biostudies-literature